Cytognomix offers many standard single copy probes previously validated by FISH  for research use. Probes have also been pre-designed covering most regions for customized production and validation for research applications. Probes have also been pre-designed covering most regions for customized production and validation for research applications. Genome-wide and targeted microarray designs available for array comparative genomic hybridization. Solution capture arrays are available for targeted sequence enrichment in deep sequencing applications.

Mutation Forecaster®

MutationForecaster® (mutationforecaster.com) is Cytognomix’s patented web-portal for analysis of all types of mutations (coding and non-coding), including interpretation, comparison and management of genetic variant data. It’s now accessible via Illumina’s BaseSpace ecosystem!

MutationForecaster® combines our world-leading genome interpretation software with the Cytognomix User Variation Database and EBI’s Variant Effect Predictor.  With our integrated suite of software products, analyze coding, non-coding, and copy number variants, and compare new results with existing or your own database.  Select predicted mutations  by phenotype using PubMed-indexed articles with Cyto Visualization Analytics.  With Workflows,  automatically perform end-to-end analysis with all of our software products on your exome, gene panel, or complete genome dataset. It’s an end-to-end genome interpretation solution for research, translational and clinical labs.   

You can now experience our integrated suite of genome interpretation products throughfree trial of MutationForecaster®. Once you register, analyze datasets that we have analyzed in our peer-reviewed publications with any of our software tools.

mutforecast

mutationforecaster.com

Read more »

Mission

We find and validate mutations that others cannot…

with advanced,  patented genomic  probe and bioinformatic technologies.

Cytognomix continues our  long track record of creating technologies for genomic medicine.

We anticipate and implement the needs of the biomedical and clinical genomics communities.

 

Read more »